0001127602-24-015691.txt : 20240516
0001127602-24-015691.hdr.sgml : 20240516
20240516163550
ACCESSION NUMBER: 0001127602-24-015691
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240515
FILED AS OF DATE: 20240516
DATE AS OF CHANGE: 20240516
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MASSARO GEORGE
CENTRAL INDEX KEY: 0001221496
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-15943
FILM NUMBER: 24956167
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
CENTRAL INDEX KEY: 0001100682
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 061397316
FISCAL YEAR END: 1228
BUSINESS ADDRESS:
STREET 1: 251 BALLARDVALE ST
CITY: WILMINGTON
STATE: MA
ZIP: 01887
BUSINESS PHONE: 781-222-6000
MAIL ADDRESS:
STREET 1: 251 BALLARDVALE ST
CITY: WILMINGTON
STATE: MA
ZIP: 01887
FORMER COMPANY:
FORMER CONFORMED NAME: CHARLES RIVER LABORATORIES INTERNATIONAL INC
DATE OF NAME CHANGE: 20000605
FORMER COMPANY:
FORMER CONFORMED NAME: CHARLES RIVER LABORATORIES HOLDINGS INC
DATE OF NAME CHANGE: 19991208
4
1
form4.xml
PRIMARY DOCUMENT
X0508
4
2024-05-15
0001100682
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
CRL
0001221496
MASSARO GEORGE
C/O CHARLES RIVER LABORATORIES
251 BALLARDVALE STREET
WILMINGTON
MA
01887
1
1
Common Stock
2024-05-15
4
S
0
123
234.72
D
6064
D
Common Stock
2024-05-15
4
S
0
113
235.61
D
5951
D
Common Stock
2024-05-15
4
S
0
96
236.78
D
5855
D
This transaction was executed in multiple trades at prices ranging from $234.27 to $235.05. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a 10b5-1 trading plan.
This transaction was executed in multiple trades at prices ranging from $235.35 to $236.16. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a 10b5-1 trading plan.
This transaction was executed in multiple trades at prices ranging from $236.36 to $237.18. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a 10b5-1 trading plan.
/s/ George E. Massaro
2024-05-15